[Theoretical principles and in vivo measurements for optimizing selective overacidification of cancer tissue. Programming of continuous intravenous infusion of glucose for stationary, greatest possible concentrations of glucose and lactic acid in the tumor].
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002296:Carcinosarcoma / Q000097:blood / Q000188:drug therapy / Q000378:metabolism; D004566:Electrodes; D005947:Glucose / Q000008:administration & dosage* / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007275:Injections, Intravenous / Q000295:instrumentation; D007773:Lactates / Q000378:metabolism*; D008297:Male; D008433:Mathematics; D008722:Methods; D051379:Mice; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D009374:Neoplasms, Experimental / Q000097:blood / Q000188:drug therapy / Q000378:metabolism; D011817:Rabbits; D051381:Rats
D001786:Blood Glucose; D007773:Lactates; D005947:Glucose
Theoretische Grundlagen und in vivo-Messungen zur Optimierung der selektiven Ubersäuerung von Krebsgewebe. Programmierung der intravenösen Dauerinfusion von Glukose für stationäre, möglichst hohe Konzentrationen von Glukose und Milchsäure im Tumor.